Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2009 10:01 ET | Source: Cytomedix, Inc.

Cytomedix Appoints Dr. Craig Mendelsohn to Board of Directors

ROCKVILLE, Md., Nov. 13, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
November 11, 2009 16:20 ET | Source: Cytomedix, Inc.

Cytomedix Reports Third Quarter Financial Results

ROCKVILLE, Md., Nov. 11, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex: GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
October 30, 2009 10:48 ET | Source: Cytomedix, Inc.

Cytomedix to Host Third Quarter and Nine Months 2009 Financial Results Conference Call on Thursday, November 12, 2009

ROCKVILLE, Md., Oct. 30, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
October 27, 2009 08:00 ET | Source: Cytomedix, Inc.

Cytomedix to Present at the 8th Annual Bio Investor Forum

ROCKVILLE, Md., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
October 15, 2009 10:36 ET | Source: Cytomedix, Inc.

Cytomedix to Present At Growth Stock Conference Hosted by Security Research Associates, Inc.

ROCKVILLE, Md., Oct. 15, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
September 30, 2009 10:00 ET | Source: Cytomedix, Inc.

Cytomedix Enters License Agreement With Millennia Holdings for Exclusive Rights to the AutoloGel System in Japan

ROCKVILLE, Md., Sept. 30, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
September 09, 2009 08:00 ET | Source: Cytomedix, Inc.

Cytomedix CEO Issues Shareholder Update

ROCKVILLE, Md., Sept. 9, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) announced today that Chief Executive Officer, Martin Rosendale, issued the following letter to shareholders providing...
August 27, 2009 08:30 ET | Source: Cytomedix, Inc.

Cytomedix Announces Subsequent and Final Closing of Registered Direct Offering of Common Stock and Warrants

ROCKVILLE, Md., Aug. 27, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) ("the Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
August 12, 2009 09:01 ET | Source: Cytomedix, Inc.

Cytomedix Announces Registered Direct Offering of Common Stock and Warrants

ROCKVILLE, Md., Aug. 12, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) ("the Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
August 10, 2009 09:50 ET | Source: Cytomedix, Inc.

Cytomedix Second Quarter Financial Results Feature Product Sales Up 72% Over First Quarter

ROCKVILLE, Md., Aug. 10, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) ("the Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...